Search

Your search keyword '"Sharmin, Salma"' showing total 12 results
Start Over Author "Sharmin, Salma"
12 results on '"Sharmin, Salma"'

1. HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer

Author

Ferretti, Giulia D. S., Quaas, Colleen E., Bertolini, Irene, Zuccotti, Alessandro, Saatci, Ozge, Kashatus, Jennifer A., Sharmin, Salma, Lu, David Y., Poli, Adi Narayana Reddy, Quesnelle, Abigail F., Rodriguez-Blanco, Jezabel, de Cubas, Aguirre A., Hobbs, G. Aaron, Liu, Qin, O’Bryan, John P., Salvino, Joseph M., Kashatus, David F., Sahin, Ozgur, and Barnoud, Thibaut

Published
2024
Full Text
View/download PDF

6. Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh

Author

Williams, Frank B, primary, Kader, Abdul, additional, Colgate, E Ross, additional, Dickson, Dorothy M, additional, Carmolli, Marya, additional, Uddin, Muhammad Ikhtear, additional, Sharmin, Salma, additional, Islam, Shahidul, additional, Bhuiyan, Taufiqur Rahman, additional, Alam, Masud, additional, Nayak, Uma, additional, Mychaleckyj, Josyf C, additional, Petri, William A, additional, Haque, Rashidul, additional, Qadri, Firdausi, additional, Kirkpatrick, Beth D, additional, and Lee, Benjamin, additional

Published
2020
Full Text
View/download PDF

7. Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh.

Author

Williams, Frank B, Kader, Abdul, Colgate, E Ross, Dickson, Dorothy M, Carmolli, Marya, Uddin, Muhammad Ikhtear, Sharmin, Salma, Islam, Shahidul, Bhuiyan, Taufiqur Rahman, Alam, Masud, Nayak, Uma, Mychaleckyj, Josyf C, Petri, William A, Haque, Rashidul, Qadri, Firdausi, Kirkpatrick, Beth D, and Lee, Benjamin

Subjects
VACCINE effectiveness, ORAL vaccines, ROTAVIRUS vaccines, CLINICAL trial registries, INFANTS, RESEARCH, VACCINES, RETROVIRUS diseases, COMPARATIVE studies, BREASTFEEDING, QUESTIONNAIRES, RESEARCH funding, ROTAVIRUSES, VIRAL antibodies
Abstract

Secretor status controls mucosal histo-blood group antigen expression and is associated with susceptibility to rotavirus (RV) diarrhea, with nonsecretors less susceptible to symptomatic infection. The role of breast milk secretor status on oral live-attenuated RV vaccine response in breastfed infants has not been explored. In a monovalent G1P[8] RV vaccine (Rotarix) trial in Bangladesh, RV-specific plasma immunoglobulin A antibody seroconversion rates were higher among infants of maternal nonsecretors (39%) than infants of maternal secretors (23%; P = .001). Maternal status remained a significant predictor when correcting for infant status (P = .002). Maternal secretor status should be considered when interpreting oral RV vaccine responses in low- and middle-income settings. Clinical Trials Registration. NCT01375647. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

11. Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014

Author

Chowdhury, Fahima, primary, Mather, Alison E., additional, Begum, Yasmin Ara, additional, Asaduzzaman, Muhammad, additional, Baby, Nabilah, additional, Sharmin, Salma, additional, Biswas, Rajib, additional, Ikhtear Uddin, Muhammad, additional, LaRocque, Regina C., additional, Harris, Jason B., additional, Calderwood, Stephen B., additional, Ryan, Edward T., additional, Clemens, John D., additional, Thomson, Nicholas R., additional, and Qadri, Firdausi, additional

Published
2015
Full Text
View/download PDF

12. High quality reference genomes for toxigenic and non-toxigenic Vibrio cholerae serogroup O139

Author

Dorman, Matthew J, Domman, Daryl, Uddin, Muhammad Ikhtear, Sharmin, Salma, Afrad, Mokibul Hassan, Begum, Yasmin Ara, Qadri, Firdausi, and Thomson, Nicholas R

Subjects
Cholera Toxin, Drug Resistance, Bacterial, Genetic Variation, O Antigens, Bacteriophages, bacterial infections and mycoses, Serogroup, Genome, Bacterial, Phylogeny, Vibrio cholerae O139, 3. Good health
Abstract

Toxigenic Vibrio cholerae of the O139 serogroup have been responsible for several large cholera epidemics in South Asia, and continue to be of clinical and historical significance today. This serogroup was initially feared to represent a new, emerging V. cholerae clone that would lead to an eighth cholera pandemic. However, these concerns were ultimately unfounded. The majority of clinically relevant V. cholerae O139 isolates are closely related to serogroup O1, biotype El Tor V. cholerae, and comprise a single sublineage of the seventh pandemic El Tor lineage. Although related, these V. cholerae serogroups differ in several fundamental ways, in terms of their O-antigen, capsulation phenotype, and the genomic islands found on their chromosomes. Here, we present four complete, high-quality genomes for V. cholerae O139, obtained using long-read sequencing. Three of these sequences are from toxigenic V. cholerae, and one is from a bacterium which, although classified serologically as V. cholerae O139, lacks the CTXφ bacteriophage and the ability to produce cholera toxin. We highlight fundamental genomic differences between these isolates, the V. cholerae O1 reference strain N16961, and the prototypical O139 strain MO10. These sequences are an important resource for the scientific community, and will improve greatly our ability to perform genomic analyses of non-O1 V. cholerae in the future. These genomes also offer new insights into the biology of a V. cholerae serogroup that, from a genomic perspective, is poorly understood.

Catalog

Books, media, physical & digital resources
See catalog results